Targeting nuclear kinases in cancer: Development of cell cycle kinase inhibitors by PITTS, Todd M, DAVIS, S. Lindsey, ECKHARDT, S. Gail, BRADSHAW-PIERCE, Erica L

Get full text

AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors by Plimack, Elizabeth R., LoRusso, Patricia M., McCoon, Patricia, Tang, Weifeng, Krebs, Annetta D., Curt, Gregory, Eckhardt, S. Gail

Get full text

Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors by Macaulay, Valentine M, Middleton, Mark R, Eckhardt, S Gail, Rudin, Charles M, Juergens, Rosalyn A, Gedrich, Richard, Gogov, Sven, McCarthy, Sean, Poondru, Srinivasu, Stephens, Andrew W, Gadgeel, Shirish M

Get full text

Identification of predictive markers of response to the MEK1/2 inhibitor selumetinib (AZD6244) in K-ras-mutated colorectal cancer by Tentler, John J, Nallapareddy, Sujatha, Tan, Aik Choon, Spreafico, Anna, Pitts, Todd M, Morelli, M Pia, Selby, Heather M, Kachaeva, Maria I, Flanigan, Sara A, Kulikowski, Gillian N, Leong, Stephen, Arcaroli, John J, Messersmith, Wells A, Eckhardt, S Gail

Get full text

Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients by RAMASWAMY, Bhuvaneswari, ELIAS, Anthony D, ECKHARDT, S. Gail, SHAPIRO, Charles L, KELBICK, Nicole T, DODLEY, Angela, MORROW, Mark, HAUGER, Marsha, ALIEN, Joan, RHOADES, Chris, KENDRA, Kari, CHEN, Helen X

Get full text

Targeting the protein ubiquitination machinery in melanoma by the NEDD8-activating enzyme inhibitor pevonedistat (MLN4924) by Wong, Kit Man, Micel, Lindsey N., Selby, Heather M., Tan, Aik Choon, Pitts, Todd M., Bagby, Stacey M., Spreafico, Anna, Klauck, Peter J., Blakemore, Stephen J., Smith, Peter F., McDonald, Alice, Berger, Allison, Tentler, John J., Eckhardt, S. Gail

Get full text

A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors by BASCHE, Michele, GUSTAFSON, Daniel L, KANGAS, Michael, ROBERTS, Kaye, NGUYEN, Thu, DAVIS, Kat, ADDISON, Russell S, MOORE, Jane C, ECKHARDT, S. Gail, HOLDEN, Scott N, O'BRYANT, Cindy L, GORE, Lia, WITTA, Samir, SCHULTZ, Mary Kay, MORROW, Mark, LEVIN, Adrah, CREESE, Brian R

Get full text

A Phase I Pharmacokinetic and Pharmacodynamic Study of S-3304, a Novel Matrix Metalloproteinase Inhibitor, in Patients with Advanced and Refractory Solid Tumors by CHIAPPORI, Alberto A, ECKHARDT, S. Gail, MEKHAIL, Tarek, O'BRYANT, Cindy L, CREAVEN, Patrick J, BUKOWSKI, Ronald, SULLIVAN, Daniel M, IKEDA, Minoru, YANO, Yoshitaka, YAMADA-SAWADA, Takuko, KAMBAYASHI, Yoshikaze, TANAKA, Kazushige, JAVLE, Milind M

Get full text

A Phase I and Pharmacokinetic Study of Col-3 (Metastat), an Oral Tetracycline Derivative with Potent Matrix Metalloproteinase and Antitumor Properties by SYED, Samira, TAKIMOTO, Chris, ROWINSKY, Eric K, HIDALGO, Manuel, RIZZO, Jinee, KUHN, John G, HAMMOND, Lisa A, SCHWARTZ, Garry, TOLCHER, Anthony, PATNAIK, Amita, ECKHARDT, S. Gail

Get full text

A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in pat... by Chow, Laura Q. M., Eckhardt, S. Gail, O’Bryant, Cindy L., Schultz, Mary Kay, Morrow, Mark, Grolnic, Stacy, Basche, Michele, Gore, Lia

Get full text

A phase I pharmacological and biological study of PI-88 and docetaxel in patients with advanced malignancies by Chow, Laura Q. M., Gustafson, Daniel L., O’Bryant, Cindy L., Gore, Lia, Basche, Michele, Holden, Scott N., Morrow, Mark C., Grolnic, Stacy, Creese, Brian R., Roberts, Kaye L., Davis, Kat, Addison, Russell, Eckhardt, S. Gail

Get full text

A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapy by Lieu, Christopher, Chow, Laura, Pierson, A. Scott, Eckhardt, S. Gail, O’Bryant, Cindy L., Morrow, Mark, Tran, Zung Vu, Wright, John J., Gore, Lia

Get full text

A Phase I and Pharmacokinetic Study of Exisulind and Docetaxel in Patients with Advanced Solid Tumors by WITTA, Samir E, GUSTAFSON, Daniel L, LONG, Michael E, GIBBS, Amy, KELLY, Karen, BUNN, Paul A, CHAN, Daniel C, PALLANSCH, Patrick, ECKHARDT, S. Gail, PIERSON, A. Scott, MENTER, Alexander, HOLDEN, Scott N, BASCHE, Michele, PERSKY, Martha, O'BRYANT, Cindy L, CHAN ZENG, BARON, Anna

Get full text

Development and Validation of a Drug Activity Biomarker that Shows Target Inhibition in Cancer Patients Receiving Enzastaurin, a Novel Protein Kinase C-{beta} Inhibitor by Green, Lisa J, Marder, Philip, Ray, Chad, Cook, Carolyn A, Jaken, Susan, Musib, Luna C, Herbst, Roy S, Carducci, Michael, Britten, Carolyn D, Basche, Michele, Eckhardt, SGail, Thornton, Donald

Get full text